All Type of News
New GMP regulations to be released until Jan. 19
The enforcement regulations of a new current good manufacturing practice (cGMP) system and validation procedures are scheduled to be promulgated within this week, according to a government official.
Now that the fi...
More focus on new drug projects, experts say
Korea should seek to expand its spending in research and development (R&D) as part of efforts to cope with in the era of free trade agreements (FTAs), experts point out.
They emphasize that the government should st...
Daewoong Pharm supports normalization of WithPharm management
WithPharm says Daewoong Pharm agreed to normalize the aggravating management of WithPharm in its recent shareholders meeting.
We are deeply appreciative of shareholders' financial support for us. We are ready for f...
Pfizer Korea wins 'Drug Safety Monitoring Award'
Pfizer Korea won the annual Drug Safety Monitoring Award for consecutive three years from the Korea Food and Drug Administration.
The award is given a company or medical institution that made voluntary reports on s...
VGX International to initiate Phase I clinical studies of VGX-1027
VGX International is planning to conduct its Phase I clinical studies of VGX-1027, a novel small molecule compound with potent anti-inflammatory activity, in healthy volunteers jointly with its affiliate, VGX Pharmace...
Hanmi's 10 drugs break W10 billion barrier in 2007
Hanmi Pharm says its 10 flagship products exceeded 10 billion won in sales last year, up two products from 2006.
By sales, Amodipin (amodipine camsylate) topped the list with 55.5 billion won, followed by Medilac (...
KFDA to examine adverse reactions with Champix
The Korea Food and Drug Administration says that it instructed Pfizer Korea to include adverse reactions of its smoking cessation drug Champix to an insert paper.
Champix has been in the news a bit recently as ther...
Green Cross Corporation received US FDA certification for biological plant
Green Cross Corporation said it has received a written certification on the design of its biological plant at Ochang of North Chungcheng Province, from the U.S. Food and Drug Administration at the end of last month.
...
Sprycel recognized as essential medicine
BMS Korea says its Sprycel (dasatinib), an oral inhibitor of multiple tyrosine kinases, has been recommended for use as one of essential medicines from the national deliberation committees consisting of oncologists.
...
Janssen Korea to launch new protease inhibitor
Janssen Korea says it will launch its new protease inhibitor Prezista (darunavir) sooner or later after being placed on the list of health insurance guaranteed products.
Prezista, which was approved by the U.S. Foo...
